Novel mutations in <i>MEN1</i> , <i>CDKN1B</i> and <i>AIP</i> genes in patients with multiple endocrine neoplasia type 1 syndrome in Spain

Abstract

Our data support that MEN1 gene is the main target for genetic analysis in clinical MEN1 syndrome. We confirm that in those patients without MEN1 gene mutation, other genes such as CDKN1B/p27Kip, or AIP in those including pituitary tumours should also be tested.